Complex effects of interferon-α on the cytokine network in HIV infection - Possible contribution to immunosuppression

Cytokine

Volumn 14, Issue 1, 2001, Pages 56-62

  Stylianou, Eva ^a   Aukrust, Pål ^a   Müller, Fredrik ^a   Nordøy, Ingvild ^a   Frøland, Stig S ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

HIV infection; IFN ; IL 10; IL 12; IL 2

Indexed keywords

ALPHA INTERFERON; CD28 ANTIGEN; CD3 ANTIGEN; CYTOKINE; DIDANOSINE; INDINAVIR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; LAMIVUDINE; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; NELFINAVIR; PHYTOHEMAGGLUTININ; STAVUDINE; ZIDOVUDINE;

ADULT; AGED; ARTICLE; CANDIDA; CELL CULTURE; CELL STIMULATION; CELL SUBPOPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

CANDIDA;

EID: 0035820186     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.2000.0850     Document Type: Article

References (38)

1. + T helper cell depletion occurs
2. + cell numbers and clinical staging
3. A Th1 → Th2 switch is a critical step in the etiology of HIV infection
4. Ability of HIV to promote a Th1 to Th0 shift and to replicate preferentially in Th2 and Th0 cells
5. Host factors and the pathogenesis of HIV-induced disease
6. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals
7. Interleukin-12 a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T helper cell type and cytotoxic lymphocytes
8. Interleukin-12 in the pathogenesis and therapy of HIV disease
9. The interleukin-12-mediated pathway of immune events is dysfunctional in human immunodeficiency virus-infected individuals
10. Dysregulated production of interleukin-10 (IL-10) and IL-12 by peripheral blood lymphocytes from human immuno-deficiency virus-infected individuals is associated with altered proliferative responses to recall antigens
11. Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro
12. In vitro restoration of T cell immune function in human immunodeficiency virus-positive persons: Effects of interleukin (IL)-12 and anti IL-10
13. Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activity of lymphocytes from patients with the acquired immunodeficiency syndrome
14. + T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy
15. Randomized, controlled phase I trial of subcutaneous interleukin-2 in combination with highly active antiretroviral therapy (HAART) in HIV patients
16. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with human immunodeficiency virus
17. Interleukin (IL)-10 in HIV infection: Increasing serum IL-10 levels with disease progression - Downregulatory effect of potent antiretroviral therapy
18. Properties and functions of interleukin-10
19. The interferons: Mechanisms of action and clinical applications
20. How cells respond to interferons
21. Lymphoblastoid interferon-alpha inhibits T cell proliferation and expression of eosinophil-activating cytokines
22. Interferons and their role in inflammation
23. Natural human interferon-α augments interleukin-2 production by a direct action on the activated IL-2 producing T cells
24. + T cells and monocytes
25. Interferons in the pathogenesis and treatment of human immunodeficiency virus infection
26. Interferons in the persistence, pathogenesis and treatment of HIV infection
27. Immunobased therapeutics: Scientific rationale and the promising approaches to the treatment of the human immuno-deficiency virus-infected individual
28. Low dose oral interferon alpha 2a in HIV-1 seropositive patients: A double blind, placebo-controlled trial
29. Active anti-interferon-alpha immunization: A European-Israeli, randomized, double-blind, placebo-controlled clinical trial in 242 HIV-l-infected patients (the EURIS study)
30. Candida albicans and candida krusei differentially induce human blood mononuclear cell interleukin-12 and gamma interferon production
31. Interferons and interferon-inducible protein 10 during highly active antiretroviral therapy (HAART) - Possible immunosuppressive role of interferon-α in HIV infection
32. The taming of IL-12: Suppressing the production of proinflammatory cytokines
33. Interferon α/β inhibition of interleukin 12 and interferon-γ production in vitro and endogenously during viral infection
34. Type I interferon (IFN α/β) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite
35. IFN-α priming of human monocytes differentially regulates gram-positive and gram negative bacteria-induced IL-10 release and selectively enhances IL-12p70, CD80, and MHC class I expression
36. Interferon α and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS
37. Impaired in vitro survival of monocytes from patients with HIV infection
38. Increased activation of protein kinase A type I contributes to the T cell deficiency in common variable immunodeficiency